| IMNM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the IMNM shares outstanding history going back to 10/1/2020:
Also see: IMNM Market Cap History IMNM YTD Return |
As of 2/27/2026 Immunome has 113.13 million IMNM shares outstanding. Investors often track the IMNM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows IMNM share count trends over time, with 21 historical shares outstanding datapoints presented, dating back to 10/1/2020.

| IMNM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the IMNM shares outstanding history going back to 10/1/2020:
Also see: IMNM Market Cap History IMNM YTD Return |
| IMNM Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||
IMNM Historical Shares Outstanding: +58.74% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||
| IMNM Stock Price Chart |
| About Immunome Inc |
| Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. Co.'s portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugates (ADCs). Its memory B cell hybridoma technology allows for the screening and functional characterization of novel antibodies and targets. Its programs include Oncology (IMM-ONC-01), LU FAP, and SARS-CoV-2 (IMM-BCP-01). The oncology program is an antibody (IMM-ONC-01) against interleukin-38 (IL-38) a novel immune modulator for the treatment of various solid tumors. We show 21 historical shares outstanding datapoints in our coverage of IMNM's shares outstanding history. Understanding the changing numbers of IMNM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMNM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMNM by allowing them to research IMNM shares outstanding history as well as any other stock in our coverage universe. |
| IMNM Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| IMNM Share Performance |
| Shares Outstanding Peers |
| Immunome (IMNM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
IMNN Shares Outstanding History IMNP Shares Outstanding History IMPL Shares Outstanding History IMRA Shares Outstanding History IMRX Shares Outstanding History IMUX Shares Outstanding History IMV Shares Outstanding History IMVT Shares Outstanding History INAB Shares Outstanding History INBS Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.